| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 361 | 469 | 2,067 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 361 | 469 | 2,067 | | | Operating Expenses | | Research Development | 3,878 | 11,940 | 3,396 | | Selling General and Administrative | 4,722 | 6,716 | 3,123 | | Non Recurring | 351 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (8,590) | (18,187) | (4,452) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 137 | 566 | 180 | | Earnings Before Interest And Taxes | (8,453) | (17,621) | (4,272) | | Interest Expense | 1,868 |
-
|
-
| | Income Before Tax | (10,321) | (17,621) | (4,272) | | Income Tax Expense | (735) | (658) | (467) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,586) | (16,963) | (3,805) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,586) | (16,963) | (3,805) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,586) | ($16,963) | ($3,805) |
|
0.01% Nasdaq 0.00%
Income Statement
